Cipla Limited (NSE:CIPLA)
India
· Delayed Price · Currency is INR 1,504.20
+14.40 (0.97%)
Jun 6, 2025, 3:30 PM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| Pharmaceuticals | 248.42B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Growth | 12.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Ventures | 11.12B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Ventures Growth | 5.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Inter Segment | -1.80B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Inter Segment Growth | -40.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| India | 108.73B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India Growth | 10.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 75.02B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 26.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World | 49.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World Growth | 7.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Africa | 24.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Africa Growth | 4.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|